论文部分内容阅读
目的:分析尿激酶(UK)静脉溶栓治疗急性心肌梗死的疗效。方法:急性心肌梗死患者50例,分别行尿激酶静脉溶栓治疗和常规治疗各25例,比较其治疗效果。结果:尿激酶静脉溶栓组心电图ST段下降率达88%,胸痛缓解率达84%,常规治疗组ST段下降率为48%,胸痛缓解率36%,两组比较差异有显著性(P<0.01)。结论:尿激酶溶栓治疗急性心肌梗死安全有效,不良反应少。
Objective: To analyze the curative effect of urokinase (UK) intravenous thrombolysis on acute myocardial infarction. Methods: 50 patients with acute myocardial infarction were treated with intravenous thrombolytic therapy of urokinase and routine treatment of 25 cases, the treatment effect was compared. Results: The ST segment depression rate of 88% and chest pain rate of 84% in the intravenous thrombolytic group were significantly lower than those in the conventional treatment group (48%) and 36% (36%) in the ST group <0.01). Conclusion: Urokinase thrombolytic therapy for acute myocardial infarction is safe and effective with few adverse reactions.